Established as a partnership in global health, the Global Fund works closely with a wide diversity of partners –implementing governments, donors, civil society, international development organizations, the private sector and communities living with and affected by the diseases. This partnership model actively supports country-owned approaches that develop and implement effective, evidence-based programs to respond to AIDS, tuberculosis and malaria.
Announcement - 26 November 2014
Global Fund Calls for End to Compulsory Treatment
Announcement - 25 November 2014
Global Fund Analysis of Audits and Investigations
News Release - 21 November 2014
Global Fund Board Considers Strategy, Governance, Ethics
News Release - 12 November 2014
Norway Signs Multi-Year Contribution to Global Fund
Announcement - 31 October 2014
Johannes Hunger Appointed as Head of Strategic Information
Turning the Tide Against HIV and Tuberculosis: Global Fund Investment Guidance for Eastern Europe and Central Asia
27 November 2014
No Cost, Huge Benefit: a Life Saved
20 November 2014
Good Nutrition to Support HIV Treatment Effectiveness
14 November 2014
Counseling and Testing for Tens of Thousands of People in Gambia
Under the oversight of the TERG, the
Five-Year Evaluation [ PDF - 133 KBEnglishEspañolFrançais ] was a major effort to review the functioning and performance of the Global Fund as an institution and a partnership, and to identify areas of strength and weakness that would lead to improving day-to-day operations. The three overarching questions that guided the structure of the evaluation are outlined below. One of the most unique aspects of this evaluation was its attempt to measure impact – that is, to assess the reduction in the burden of HIV, TB and malaria associated with the collective scale-up of prevention and treatment activities by all partners.
Study Area 1 of the Five-Year Evaluation was completed in November 2007 and examined the organizational efficiency and effectiveness of the Global Fund, its progress to date and critical areas for improvement. Study Area 2, which examined the Global Fund’s partner environment in 16 countries and at the global level was presented to the Board in November 2008. Study Area 3, the Health Impact Evaluation, involved the examination of the collective impact on the burden of AIDS, TB and malaria in 18 countries, and was the most extensive component of the Five-Year Evaluation. The Synthesis Report comprised the final deliverable of the Five-Year Evaluation and provided essential analytical linkages across all three study areas along with a synthesis of findings and recommendations. The final reports on Study Area 3 and the Synthesis Report were presented to the Global Fund Board in May 2009. Each element of the evaluation was designed to generate actionable findings and the Global Fund is committed to learn from and make concrete improvements based on these findings.
The TERG initiated an objective and collaborative process for the selection of countries to be studied under the Five-Year Evaluation. A total of 16 countries was selected for inclusion in Study Area 2, which focused on the Global Fund partnership environment. A set of 20 countries was selected for study under Study Area 3 Impact Evaluation, with 8 countries engaging in an in-depth analysis including primary data collection and 12 countries where impact analysis was based on secondary data. Country representatives and technical partners met at the Partners in Impact Forum in March 2007 to present and discuss country impact evaluation plans.
The following important background documents are available to download:
Overarching Questions for Five-Year Evaluation
Study Area 1: Organizational Efficiency
Does the Global Fund as an organization (Board, Secretariat, TRP, LFAs) through both its policies and operations, reflect the core principles, including:
In fulfilling these principles, does the Global Fund as an organization perform in an efficient and effective manner?
Study Area 2: Partnership Environment
How effective and efficient is the Global Fund partnership system (1) in supporting HIV, malaria, and TB programs at the global and country level?
Study Area 3: Health Impact
What is the Global Fund’s contribution to reducing the burden of the three diseases? What has been the overall reduction on the burden of the three diseases?
The Global Fund is committed to the highest standards of accountability and responsibility. If you have heard of any instance of inappropriate use of money related to the Global Fund, please report it immediately, here: Report Fraud and Abuse
© 2014 The Global Fund to Fight AIDS, Tuberculosis and Malaria